ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan · Delayed Price · Currency is TWD 19.70
+0.10 (0.51%)
Jun 3, 2026, 1:30 PM CST
ShareHope Medicine Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 128.54 | 141.73 | 200.1 | 124.56 | 293.95 | 232.66 |
Depreciation & Amortization | 249.11 | 257.04 | 294 | 308.13 | 299.65 | 298.45 |
Other Amortization | 11.28 | 11.28 | 16.45 | 13.41 | 9.65 | 6.07 |
Loss (Gain) From Sale of Assets | -2.99 | -4.61 | -136.61 | -23.91 | -9.2 | -3.71 |
Asset Writedown & Restructuring Costs | 1.26 | 1.26 | 41.65 | - | 51.47 | 25.65 |
Loss (Gain) From Sale of Investments | 1.03 | 3.7 | -8.32 | -8.89 | -2.9 | -38.59 |
Loss (Gain) on Equity Investments | 1.73 | 1.23 | -0.44 | 1.85 | 0.4 | 0.22 |
Stock-Based Compensation | - | - | - | - | - | 3.27 |
Provision & Write-off of Bad Debts | 2.7 | 4.42 | 10.95 | 3.09 | -2.03 | -15.52 |
Other Operating Activities | -22.68 | -24.44 | -152.86 | -70.99 | -62.51 | -75.2 |
Change in Accounts Receivable | 31.22 | 40.57 | 123.66 | -147.32 | -144.99 | 19.55 |
Change in Inventory | -16.04 | 0.4 | 3.86 | -0.52 | 18.84 | 40.62 |
Change in Accounts Payable | 59.17 | 16.34 | -79.91 | 44.08 | 150.85 | -88.82 |
Change in Unearned Revenue | -16.7 | -31.56 | 36.41 | 7.04 | -1.76 | -4.3 |
Change in Other Net Operating Assets | 1 | -53.23 | -82.27 | 6.6 | 41.04 | -40.27 |
Operating Cash Flow | 428.63 | 364.13 | 266.68 | 257.13 | 642.47 | 360.1 |
Operating Cash Flow Growth | 119.94% | 36.54% | 3.71% | -59.98% | 78.41% | -49.83% |
Capital Expenditures | -108.84 | -123.98 | -83.07 | -250.31 | -1,266 | -137.51 |
Sale of Property, Plant & Equipment | 10.86 | 10.76 | 58.11 | 40.53 | 110.57 | 3.57 |
Divestitures | - | - | 2.81 | - | - | - |
Sale (Purchase) of Intangibles | -8.25 | -7.66 | -9.95 | -26.9 | -18.07 | -14.56 |
Sale (Purchase) of Real Estate | - | 240 | 53.15 | - | - | - |
Investment in Securities | 10.59 | -14.59 | -39.21 | 58.85 | -182.25 | -7.25 |
Other Investing Activities | -228.98 | -225.6 | 53.27 | -49.78 | -17.85 | -164.96 |
Investing Cash Flow | -324.64 | -121.07 | 35.11 | -227.6 | -1,374 | -320.71 |
Short-Term Debt Issued | - | - | 25.62 | 101.21 | 30.52 | 19.99 |
Long-Term Debt Issued | - | 836 | 2.55 | 158.3 | 1,194 | 15.84 |
Total Debt Issued | -7.06 | 836 | 28.17 | 259.51 | 1,225 | 35.83 |
Short-Term Debt Repaid | - | -56.72 | - | - | - | -67.63 |
Long-Term Debt Repaid | - | -1,066 | -236.28 | -151.33 | -476.96 | -230.89 |
Total Debt Repaid | -236.38 | -1,122 | -236.28 | -151.33 | -476.96 | -298.52 |
Net Debt Issued (Repaid) | -243.44 | -286.34 | -208.11 | 108.18 | 747.56 | -262.69 |
Repurchase of Common Stock | - | - | -9 | -227.43 | - | - |
Common Dividends Paid | -65.54 | -65.54 | -50.42 | -60.02 | -57.16 | -102.8 |
Other Financing Activities | -7.05 | -8 | 40.31 | -1.11 | 15.89 | 202.09 |
Financing Cash Flow | -316.04 | -359.88 | -227.22 | -180.39 | 706.28 | -163.41 |
Foreign Exchange Rate Adjustments | -4.42 | -4.13 | 2.05 | -1.3 | 2.83 | -5.37 |
Net Cash Flow | -216.46 | -120.95 | 76.61 | -152.16 | -21.99 | -129.38 |
Free Cash Flow | 319.79 | 240.15 | 183.6 | 6.83 | -623.51 | 222.59 |
Free Cash Flow Growth | 197.61% | 30.80% | 2589.38% | - | - | -38.14% |
Free Cash Flow Margin | 7.30% | 5.51% | 4.24% | 0.18% | -15.07% | 5.78% |
Free Cash Flow Per Share | 2.31 | 1.74 | 1.33 | 0.05 | -4.50 | 1.60 |
Cash Interest Paid | 47.44 | 47.99 | 57.41 | 48.9 | 36.85 | 19.73 |
Cash Income Tax Paid | 19.41 | 19.41 | 76.56 | 57.65 | 104.31 | 110.92 |
Levered Free Cash Flow | 257.37 | 432.43 | -31.2 | -106.81 | -622.19 | 85.96 |
Unlevered Free Cash Flow | 286.83 | 462.31 | 1.78 | -74.25 | -600.52 | 98.52 |
Change in Working Capital | 58.66 | -27.48 | 1.75 | -90.12 | 63.99 | -73.22 |